MacLean Michael F 4
4 · Avidity Biosciences, Inc. · Filed Jan 8, 2025
Insider Transaction Report
Form 4
MacLean Michael F
Chief Financial Officer
Transactions
- Award
Common Stock
2025-01-06+25,000→ 107,942 total - Award
Stock Option (Right to Buy)
2025-01-06+50,000→ 50,000 totalExercise: $31.42Exp: 2035-01-05→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in four equal installments on the first four anniversaries of January 6, 2025, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
- [F2]This option vests in 48 equal installments on each monthly anniversary of the grant date, until it is fully vested on January 6, 2029.